Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

Drug Approval

wooden blocks spell out the word content with word bubbles above that say news and stories and photos and blog
Blog Post

In Case You Missed It…

By MDA Staff | November 8, 2023
Blog Post

AGAMREE ® (Vamorolone), Now FDA-Approved, Offers Hope for Children Living with Duchenne Muscular Dystrophy

By MDA Staff | October 26, 2023
A young girl with blonde hair sitting on a doctor’s table as a doctor, a woman with brown hair, uses a reflex hammer on the girl’s knee. Both girl and doctor are smiling.
Featured Article

Advances in the Treatment of Friedreich Ataxia

By MDA Staff | August 8, 2023
DNA spiral pill on black background. Genetically modified food concept.
Blog Post

DMD Gene Therapy Approval Ignites Hope

By Larry Luxner | August 1, 2023
Blog Post

FDA Approves Sarepta’s ELEVIDYS for Treatment of DMD

By Sujatha Gurunathan | June 22, 2023
Blog Post

FDA Approves argenx’s Vyvgart Hytrulo for Treatment of gMG

By Sujatha Gurunathan | June 20, 2023
Featured Article

Gene Therapy Options Grow With New Drug Approvals

By Larry Luxner | May 18, 2023
FDA approved Biogen’s Qalsody for treatment of SOD1-ALS.
Blog Post

FDA Approves Biogen’s Qalsody for Treatment of SOD1-ALS

By Sujatha Gurunathan | April 25, 2023
Blog Post

FDA Approves Reata’s SKYCLARYS for Treatment of FA

By Sujatha Gurunathan | February 28, 2023
Blog Post

MDA Celebrates the Approval of Relyvrio from Amylyx for the Treatment of ALS

By MDA Staff | September 30, 2022
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 6
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1016 W Jackson Blvd #1073
Chicago, IL 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset